Table 1 Patient demographics, lesion characteristics, treatment methods, clinical outcomes at a 1-year follow-up, and the time points, when OCT and DUS were performed.
P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | ||
|---|---|---|---|---|---|---|---|---|---|
Baseline | |||||||||
Age (in years) | 76 | 82 | 71 | 63 | 74 | 65 | 73 | 73 | |
Gender (Male/Female) | F | F | M | M | M | M | M | M | |
Fontaine stage (I–IV) | IIb | IIb | IIa | IIb | IIb | IIa | IIb | IIb | |
Lesion location | Distal SFA | Popliteal PII | Distal SFA/Popliteal P1 | Distal SFA | Mid-/Distal SFA | Mid-/Distal SFA | Distal SFA | Mid- / Distal SFA | |
Lesion length (mm) | 30 | 30 | 70 | 20 | 100 | 120 | 50 | 70 | |
Occlusion (y/n) | n | n | n | n | y | y | y | n | |
Calcification level | Severe | Moderate | Moderate–severe | Moderate | Severe | Moderate | Severe | Moderate – Severe | |
Treatment | |||||||||
PTA (device brand) diameter × length (mm) | Pirouette 35 5 × 40 | Pirouette 35 5 × 40 | Lutonix 35 6 × 120 | InPact Admiral 35 5 × 60 | Pirouette 35 6 × 40 | InPact Admiral 35 6 × 60 | Freeway 35 5 × 120 | Passeo-18 Lux 5 × 80 | |
Stent (device brand) diameter × length (mm) | – | – | – | – | Zilver PTX 6 × 120 | Zilver PTX 6 × 150 | Pulsar-18 7 × 60 | Pulsar-18 7 × 40 | |
Follow-up | |||||||||
Fontaine stage (I–IV) | I | I | I | I | I | I | I | I | |
ABI | 1 | 0.8 | 1.3 | 0.93 | 1 | - | 0.98 | 1.09 | |
Binary restenosis (y/n) | n | n | n | n | n | n | n | n | |
TLR (y/n) | n | n | n | n | n | n | n | n | |
Data acquisition | |||||||||
OCT | Pre-PTA | x | x | x | x | ||||
Post-PTA | x | x | x | x | x | x | x | ||
Post-Stent | x | x | x | x | |||||
